23 April 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighting the Role of Advanced Practice Providers (Nurse Practitioners and Physician Assistants)
Willa V. Cochran12ABCDEF*, M. Veronica Dioverti2E, Julie Langlee1AE, Lindsay N. Barker2E, Audra Shedeck3E, Lindsay P. Toman4AE, Robin K. Avery
DOI: 10.12659/AOT.941185
Ann Transplant 2024; 29:e941185
Introduction
Prophylaxis and Pre-emptive Therapy, and Detection and Monitoring of CMV in Transplant Recipients
Clinical Features of CMV Infection and Disease in Transplant Recipients
Challenges in Management: Neutropenia and Thrombocytopenia
Challenges in Management: Nephrotoxicity and Other Adverse Effects
Case Study: A Nurse Practitioner-Led Outpatient CMV Monitoring Program
Newer CMV Antivirals: Letermovir
Management of R/R CMV Infection and Disease in SOT and HCT Recipients: Challenges
Newer CMV Antivirals: Maribavir
Conclusions
References